US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VistaGen Therapeutics

0.5693

-0.0355-5.87%

Post-market: 0.5620-0.0073-1.28%19:44 EDT

Volume:531.81K

Turnover:303.84K

Market Cap:22.48M

PE:-0.30

High:0.6114

Open:0.5900

Low:0.5593

Close:0.6048

52wk High:5.14

52wk Low:0.4300

Shares:39.50M

Float Shares:30.75M

Volume Ratio:1.63

T/O Rate:1.73%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.9003

EPS(LYR):-1.6652

ROE:-101.55%

ROA:-55.53%

PB:0.44

PE(LYR):-0.34

Loading ...

Overview Company News Filings

VistaGen Therapeutics Faces Securities Class Action Over Alleged Misleading Statements

High-Risk Warning: Analyst Flags Significant Uncertainties for Vistagen Therapeutics Investors

VistaGen Therapeutics Faces Investor Class Action Over Failed Drug Trial

Stifel Nicolaus Reaffirms Their Hold Rating on VistaGen Therapeutics (VTGN)

VistaGen fiscal Q3 net loss widens to $18.9 mln

VistaGen Therapeutics Q3 EPS $(0.45) Misses $(0.44) Estimate, Sales $303.000K Miss $366.000K Estimate

BRIEF-VistaGen Q3 EPS USD -0.45

Vistagen Reports Fiscal Year 2026 Third Quarter Financial Results and Provides Corporate Update

THOMSON REUTERS

Nasdaq Warns VistaGen Therapeutics Over Minimum Bid Price Compliance

VistaGen Therapeutics Inc. to Report Third Quarter Results and Host Corporate Update Call

Press Release: Vistagen to Report Fiscal Year 2026 Third Quarter Results and Host Corporate Update Conference Call on February 12, 2026

Vistagen Therapeutics (VTGN) Faces Securities Litigation Following 80% Stock Collapse [January 2026]

VistaGen Therapeutics Reports Phase 3 Fasedienol Trial Fails to Meet Primary Endpoint in Social Anxiety Disorder

Vistagen Therapeutics Inc : William Blair Cuts to Market Perform Rating

THOMSON REUTERS

Vistagen Therapeutics Inc : Maxim Group Cuts to Hold From Buy

THOMSON REUTERS

Vistagen Therapeutics Cut to Hold From Buy by Jefferies

Sector Update: Health Care Stocks Softer Wednesday Afternoon

MT Newswires Live

Vistagen Therapeutics Shares Tumble in Premarket as Anxiety Drug Test Miss Targets

BRIEF-Vistagen Announces Topline Results From Palisade-3 Phase 3 Study

VistaGen Therapeutics Reports Phase 3 Trial of Fasedienol for Social Anxiety Disorder Fails to Meet Primary Endpoint

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/VTGN/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VTGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VTGN\",,,,,undefined,":{"symbol":"VTGN","market":"US","secType":"STK","nameCN":"VistaGen Therapeutics","latestPrice":0.5693,"timestamp":1774641600000,"preClose":0.6048,"halted":0,"volume":531810,"hourTrading":{"tag":"盘后","latestPrice":0.562,"preClose":0.5693,"latestTime":"19:44 EDT","volume":2135,"amount":1204.1934,"timestamp":1774655092618,"change":-0.0073,"changeRate":-0.012823,"amplitude":0.014052},"delay":0,"changeRate":-0.05869708994708991,"floatShares":30750300,"shares":39495451,"eps":-1.900316,"marketStatus":"Market Closed","change":-0.0355,"latestTime":"03-27 16:00:00 EDT","open":0.59,"high":0.611395,"low":0.5593,"amount":303837.624594,"amplitude":0.086136,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.900316,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1462939200000,"exchange":"NASDAQ","adjPreClose":0.6048,"preHourTrading":{"tag":"盘前","latestPrice":0.5901,"preClose":0.6048,"latestTime":"09:27 EDT","volume":5420,"amount":3251.31166,"timestamp":1774618072765,"change":-0.0147,"changeRate":-0.024306,"amplitude":0.018022},"postHourTrading":{"tag":"盘后","latestPrice":0.562,"preClose":0.5693,"latestTime":"19:44 EDT","volume":2135,"amount":1204.1934,"timestamp":1774655092618,"change":-0.0073,"changeRate":-0.012823,"amplitude":0.014052},"volumeRatio":1.62978320342925,"impliedVol":1.307,"impliedVolPercentile":0.4861},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VTGN\",,,,,undefined,":{"symbol":"VTGN","floatShares":30750300,"roa":"-55.53%","roe":"-101.55%","lyrEps":-1.66525,"volumeRatio":1.62978320342925,"shares":39495451,"dividePrice":0,"high":0.611395,"amplitude":0.086136,"preClose":0.6048,"low":0.5593,"week52Low":0.43,"pbRate":"0.44","psRate":"28.50","week52High":5.14,"institutionHeld":0,"latestPrice":0.5693,"eps":-1.900316,"divideRate":0,"volume":531810,"delay":0,"ttmEps":-1.900316,"open":0.59,"prevYearClose":0.6619,"prevWeekClose":0.609,"prevMonthClose":0.586,"prevQuarterClose":0.6619,"fiveDayClose":0.609,"twentyDayClose":0.586,"sixtyDayClose":0.6781},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VTGN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-12","symbol":"VTGN","fiscalQuarterEnding":"2025/12","expectedEps":-0.5,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1770872400000,"reportTimeType":"post","actualEps":-0.46},{"market":"US","date":"2025-11-13","symbol":"VTGN","fiscalQuarterEnding":"2025/09","expectedEps":-0.51,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.54},{"market":"US","date":"2025-08-07","symbol":"VTGN","fiscalQuarterEnding":"2025/06","expectedEps":-0.47,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-0.47},{"market":"US","date":"2025-06-17","symbol":"VTGN","fiscalQuarterEnding":"2025/03","expectedEps":-0.52,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1750132800000,"reportTimeType":"post","actualEps":-0.43},{"market":"US","date":"2025-02-13","symbol":"VTGN","fiscalQuarterEnding":"2024/12","expectedEps":-0.5,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739422800000,"reportTimeType":"post","actualEps":-0.46}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VTGN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VTGN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":5,"updateTime":1766030400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VTGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VTGN","date":"2026-03-27","current":-0.299582,"percent":0.946254,"low":-37.785134,"twenty":-7.533291,"median":-2.132332,"eighty":-0.544676,"high":-0.195082,"avg":-5.861081,"sd":8.77328,"marketCap":23962367},"quantilePoints":[{"date":"2021-04-01","current":-20.941661,"twenty":-2.570852,"median":-1.563666,"eighty":-0.742724,"marketCap":313915497},{"date":"2021-04-09","current":-20.654789,"twenty":-2.606601,"median":-1.561745,"eighty":-0.742674,"marketCap":309615285},{"date":"2021-04-16","current":-19.602925,"twenty":-2.636028,"median":-1.561745,"eighty":-0.742674,"marketCap":293847840},{"date":"2021-04-23","current":-19.507301,"twenty":-2.644829,"median":-1.561745,"eighty":-0.742674,"marketCap":292414436},{"date":"2021-04-30","current":-32.079325,"twenty":-2.679147,"median":-1.561745,"eighty":-0.742674,"marketCap":480869082},{"date":"2021-05-07","current":-32.586508,"twenty":-2.685764,"median":-1.561745,"eighty":-0.742674,"marketCap":488471755},{"date":"2021-05-14","current":-27.134291,"twenty":-2.72478,"median":-1.583089,"eighty":-0.742674,"marketCap":406743018},{"date":"2021-05-21","current":-35.756402,"twenty":-2.752079,"median":-1.598123,"eighty":-0.742674,"marketCap":535988463},{"date":"2021-05-28","current":-32.8401,"twenty":-2.768658,"median":-1.630931,"eighty":-0.742674,"marketCap":492273092},{"date":"2021-06-04","current":-30.557776,"twenty":-2.77947,"median":-1.651439,"eighty":-0.742674,"marketCap":458061062},{"date":"2021-06-11","current":-35.50281,"twenty":-2.792773,"median":-1.67478,"eighty":-0.742674,"marketCap":532187126},{"date":"2021-06-18","current":-36.643972,"twenty":-2.812661,"median":-1.694545,"eighty":-0.742674,"marketCap":549293141},{"date":"2021-06-25","current":-33.600874,"twenty":-2.818394,"median":-1.70616,"eighty":-0.742823,"marketCap":503677102},{"date":"2021-07-02","current":-36.175919,"twenty":-2.835565,"median":-1.70616,"eighty":-0.742823,"marketCap":648786166},{"date":"2021-07-09","current":-33.081224,"twenty":-2.85862,"median":-1.70616,"eighty":-0.742823,"marketCap":593285285},{"date":"2021-07-16","current":-29.239533,"twenty":-2.885827,"median":-1.70616,"eighty":-0.742823,"marketCap":524387639},{"date":"2021-07-23","current":-30.62681,"twenty":-2.916894,"median":-1.70616,"eighty":-0.742823,"marketCap":549267344},{"date":"2021-07-30","current":-28.492113,"twenty":-2.924134,"median":-1.70616,"eighty":-0.742823,"marketCap":510983246},{"date":"2021-08-06","current":-29.777471,"twenty":-2.938849,"median":-1.715533,"eighty":-0.742823,"marketCap":534035122},{"date":"2021-08-13","current":-23.693959,"twenty":-2.968928,"median":-1.732484,"eighty":-0.743545,"marketCap":534343791},{"date":"2021-08-20","current":-23.009657,"twenty":-3.016018,"median":-1.747566,"eighty":-0.760103,"marketCap":518911480},{"date":"2021-08-27","current":-26.089016,"twenty":-3.058487,"median":-1.763279,"eighty":-0.772114,"marketCap":588356882},{"date":"2021-09-03","current":-27.029931,"twenty":-3.093037,"median":-1.773644,"eighty":-0.779499,"marketCap":609576311},{"date":"2021-09-10","current":-25.832403,"twenty":-3.133777,"median":-1.781251,"eighty":-0.779499,"marketCap":582569765},{"date":"2021-09-17","current":-25.490252,"twenty":-3.173766,"median":-1.800291,"eighty":-0.779499,"marketCap":574853610},{"date":"2021-09-24","current":-24.207185,"twenty":-3.204832,"median":-1.822788,"eighty":-0.779499,"marketCap":545918025},{"date":"2021-10-01","current":-23.009657,"twenty":-3.282133,"median":-1.835745,"eighty":-0.779499,"marketCap":518911480},{"date":"2021-10-08","current":-21.555515,"twenty":-3.313145,"median":-1.858529,"eighty":-0.779499,"marketCap":486117817},{"date":"2021-10-15","current":-20.443524,"twenty":-3.350636,"median":-1.873762,"eighty":-0.779499,"marketCap":461040311},{"date":"2021-10-22","current":-19.759222,"twenty":-3.375442,"median":-1.904318,"eighty":-0.779499,"marketCap":445607999},{"date":"2021-10-29","current":-19.588146,"twenty":-3.418203,"median":-1.917993,"eighty":-0.779499,"marketCap":441749921},{"date":"2021-11-05","current":-21.127826,"twenty":-3.45338,"median":-1.936117,"eighty":-0.779578,"marketCap":476472623},{"date":"2021-11-12","current":-13.833383,"twenty":-3.484535,"median":-1.960234,"eighty":-0.80279,"marketCap":443339179},{"date":"2021-11-19","current":-13.646446,"twenty":-3.554592,"median":-1.974573,"eighty":-0.825259,"marketCap":437348109},{"date":"2021-11-26","current":-12.150945,"twenty":-3.639335,"median":-1.987522,"eighty":-0.828653,"marketCap":389419549},{"date":"2021-12-03","current":-10.406194,"twenty":-3.687422,"median":-2.014852,"eighty":-0.83885,"marketCap":333502896},{"date":"2021-12-10","current":-11.465507,"twenty":-3.752188,"median":-2.030447,"eighty":-0.842198,"marketCap":367452292},{"date":"2021-12-17","current":-11.777069,"twenty":-7.994202,"median":-2.037895,"eighty":-0.845526,"marketCap":377437409},{"date":"2021-12-23","current":-12.649445,"twenty":-11.091631,"median":-2.047717,"eighty":-0.849351,"marketCap":405395735},{"date":"2021-12-31","current":-12.150945,"twenty":-11.492175,"median":-2.058463,"eighty":-0.853568,"marketCap":389419549},{"date":"2022-01-07","current":-10.967006,"twenty":-11.590132,"median":-2.071065,"eighty":-0.859381,"marketCap":351476106},{"date":"2022-01-14","current":-10.842381,"twenty":-11.590132,"median":-2.072974,"eighty":-0.867858,"marketCap":347482059},{"date":"2022-01-21","current":-9.34688,"twenty":-11.590132,"median":-2.080397,"eighty":-0.869049,"marketCap":299553499},{"date":"2022-01-28","current":-9.596131,"twenty":-11.590132,"median":-2.089644,"eighty":-0.874837,"marketCap":307541592},{"date":"2022-02-04","current":-9.34688,"twenty":-11.590132,"median":-2.097879,"eighty":-0.880305,"marketCap":299553499},{"date":"2022-02-11","current":-8.308777,"twenty":-11.590132,"median":-2.106527,"eighty":-0.889608,"marketCap":309791932},{"date":"2022-02-18","current":-7.699467,"twenty":-11.590132,"median":-2.119816,"eighty":-0.895159,"marketCap":287073857},{"date":"2022-02-25","current":-7.754859,"twenty":-11.590132,"median":-2.123135,"eighty":-0.900425,"marketCap":289139137},{"date":"2022-03-04","current":-6.813197,"twenty":-11.590132,"median":-2.131195,"eighty":-0.912803,"marketCap":254029384},{"date":"2022-03-11","current":-6.59163,"twenty":-11.590132,"median":-2.138746,"eighty":-0.928191,"marketCap":245768266},{"date":"2022-03-18","current":-6.813197,"twenty":-11.590132,"median":-2.144456,"eighty":-0.948857,"marketCap":254029384},{"date":"2022-03-25","current":-6.536238,"twenty":-11.590132,"median":-2.154957,"eighty":-0.957849,"marketCap":243702986},{"date":"2022-04-01","current":-6.370063,"twenty":-11.590132,"median":-2.169872,"eighty":-0.963752,"marketCap":237507148},{"date":"2022-04-08","current":-7.533291,"twenty":-11.590132,"median":-2.178195,"eighty":-0.973722,"marketCap":280878018},{"date":"2022-04-14","current":-8.97348,"twenty":-11.590132,"median":-2.185127,"eighty":-0.983853,"marketCap":334575287},{"date":"2022-04-22","current":-7.699467,"twenty":-11.590132,"median":-2.196891,"eighty":-0.995258,"marketCap":287073857},{"date":"2022-04-29","current":-7.034765,"twenty":-11.590132,"median":-2.203547,"eighty":-1.006149,"marketCap":262290502},{"date":"2022-05-06","current":-7.034765,"twenty":-11.590132,"median":-2.215938,"eighty":-1.021031,"marketCap":262290502},{"date":"2022-05-13","current":-6.314671,"twenty":-11.590132,"median":-2.22671,"eighty":-1.027995,"marketCap":235441868},{"date":"2022-05-20","current":-5.816144,"twenty":-11.590132,"median":-2.236341,"eighty":-1.039985,"marketCap":216854352},{"date":"2022-05-27","current":-5.871536,"twenty":-11.590132,"median":-2.249837,"eighty":-1.053264,"marketCap":218919632},{"date":"2022-06-03","current":-6.370063,"twenty":-11.590132,"median":-2.25698,"eighty":-1.079422,"marketCap":237507148},{"date":"2022-06-10","current":-5.539185,"twenty":-11.590132,"median":-2.268657,"eighty":-1.093745,"marketCap":206527955},{"date":"2022-06-17","current":-5.475484,"twenty":-11.590132,"median":-2.28141,"eighty":-1.100513,"marketCap":204152883},{"date":"2022-06-24","current":-4.256347,"twenty":-11.590132,"median":-2.296391,"eighty":-1.115309,"marketCap":203293371},{"date":"2022-07-01","current":-3.773085,"twenty":-11.590132,"median":-2.321872,"eighty":-1.145312,"marketCap":180211576},{"date":"2022-07-08","current":-4.027479,"twenty":-11.590132,"median":-2.324352,"eighty":-1.154027,"marketCap":192362065},{"date":"2022-07-15","current":-3.375053,"twenty":-11.590132,"median":-2.341195,"eighty":-1.170145,"marketCap":161200608},{"date":"2022-07-22","current":-0.648533,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":30975479},{"date":"2022-07-29","current":-0.619113,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":29570320},{"date":"2022-08-05","current":-0.670165,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":32008683},{"date":"2022-08-12","current":-0.544468,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":32556040},{"date":"2022-08-19","current":-0.743715,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":44469814},{"date":"2022-08-26","current":-0.656198,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":39236854},{"date":"2022-09-02","current":-0.606387,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":36258411},{"date":"2022-09-09","current":-0.715004,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":42753072},{"date":"2022-09-16","current":-0.660695,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":39505741},{"date":"2022-09-23","current":-0.56038,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":33507487},{"date":"2022-09-30","current":-0.526135,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":31459808},{"date":"2022-10-07","current":-0.490506,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":29329393},{"date":"2022-10-14","current":-0.38604,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":23082936},{"date":"2022-10-21","current":-0.366323,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":21903968},{"date":"2022-10-28","current":-0.449689,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":26888802},{"date":"2022-11-04","current":-0.428934,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":25647781},{"date":"2022-11-11","current":-0.519633,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":33507487},{"date":"2022-11-18","current":-0.47633,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":30715197},{"date":"2022-11-25","current":-0.389404,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":25109932},{"date":"2022-12-02","current":-0.434631,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":28026324},{"date":"2022-12-09","current":-0.37529,"twenty":-11.590132,"median":-2.359022,"eighty":-1.172623,"marketCap":24199852},{"date":"2022-12-16","current":-0.471519,"twenty":-11.590132,"median":-2.359022,"eighty":-1.16627,"marketCap":30404942},{"date":"2022-12-23","current":-0.313384,"twenty":-11.590132,"median":-2.359022,"eighty":-1.150476,"marketCap":20207910},{"date":"2022-12-30","current":-0.330384,"twenty":-11.590132,"median":-2.359022,"eighty":-1.132526,"marketCap":21304143},{"date":"2023-01-06","current":-0.521557,"twenty":-11.590132,"median":-2.359022,"eighty":-1.111492,"marketCap":33631589},{"date":"2023-01-13","current":-0.513218,"twenty":-11.590132,"median":-2.359022,"eighty":-1.099507,"marketCap":33093815},{"date":"2023-01-20","current":-0.549143,"twenty":-11.590132,"median":-2.359022,"eighty":-1.093055,"marketCap":35410382},{"date":"2023-01-27","current":-0.679693,"twenty":-11.590132,"median":-2.341195,"eighty":-1.07824,"marketCap":43828621},{"date":"2023-02-03","current":-0.962283,"twenty":-11.590132,"median":-2.341031,"eighty":-1.04899,"marketCap":62050903},{"date":"2023-02-10","current":-0.620017,"twenty":-11.590132,"median":-2.341031,"eighty":-1.039212,"marketCap":39500707},{"date":"2023-02-17","current":-0.677853,"twenty":-11.590132,"median":-2.341031,"eighty":-1.026755,"marketCap":43185392},{"date":"2023-02-24","current":-0.614509,"twenty":-11.590132,"median":-2.341031,"eighty":-1.020438,"marketCap":39149784},{"date":"2023-03-03","current":-0.584213,"twenty":-11.590132,"median":-2.341031,"eighty":-1.006123,"marketCap":37219711},{"date":"2023-03-10","current":-0.461656,"twenty":-11.590132,"median":-2.324352,"eighty":-0.995052,"marketCap":29411687},{"date":"2023-03-17","current":-0.475426,"twenty":-11.590132,"median":-2.324352,"eighty":-0.983843,"marketCap":30288982},{"date":"2023-03-24","current":-0.47818,"twenty":-11.590132,"median":-2.324352,"eighty":-0.969566,"marketCap":30464443},{"date":"2023-03-31","current":-0.429295,"twenty":-11.590132,"median":-2.323112,"eighty":-0.962219,"marketCap":27350007},{"date":"2023-04-06","current":-0.456836,"twenty":-11.590132,"median":-2.323112,"eighty":-0.957849,"marketCap":29104619},{"date":"2023-04-14","current":-0.479902,"twenty":-11.590132,"median":-2.324352,"eighty":-0.948422,"marketCap":30574106},{"date":"2023-04-21","current":-0.486098,"twenty":-11.590132,"median":-2.324352,"eighty":-0.920451,"marketCap":30968894},{"date":"2023-04-28","current":-0.470607,"twenty":-11.590132,"median":-2.324352,"eighty":-0.896953,"marketCap":29981925},{"date":"2023-05-05","current":-0.432394,"twenty":-11.590132,"median":-2.324352,"eighty":-0.887332,"marketCap":27547401},{"date":"2023-05-12","current":-0.493328,"twenty":-11.590132,"median":-2.324352,"eighty":-0.868084,"marketCap":31429479},{"date":"2023-05-19","current":-0.48782,"twenty":-11.590132,"median":-2.324352,"eighty":-0.858687,"marketCap":31078557},{"date":"2023-05-26","current":-0.454771,"twenty":-11.590132,"median":-2.321872,"eighty":-0.847383,"marketCap":28973023},{"date":"2023-06-02","current":-0.486098,"twenty":-11.590132,"median":-2.296391,"eighty":-0.842823,"marketCap":30968894},{"date":"2023-06-09","current":-0.290328,"twenty":-11.590132,"median":-2.281329,"eighty":-0.831263,"marketCap":18496511},{"date":"2023-06-16","current":-0.238688,"twenty":-11.590132,"median":-2.262443,"eighty":-0.82638,"marketCap":15206617},{"date":"2023-06-23","current":-0.200819,"twenty":-11.590132,"median":-2.248215,"eighty":-0.803176,"marketCap":12794029},{"date":"2023-06-30","current":-0.239173,"twenty":-11.590132,"median":-2.248215,"eighty":-0.790862,"marketCap":14170462},{"date":"2023-07-07","current":-0.265748,"twenty":-11.590132,"median":-2.239504,"eighty":-0.779697,"marketCap":15744958},{"date":"2023-07-14","current":-0.239173,"twenty":-11.590132,"median":-2.233935,"eighty":-0.766212,"marketCap":14170462},{"date":"2023-07-21","current":-0.248474,"twenty":-11.590132,"median":-2.228997,"eighty":-0.754142,"marketCap":14721535},{"date":"2023-07-28","current":-0.223228,"twenty":-11.590132,"median":-2.228997,"eighty":-0.724814,"marketCap":13225764},{"date":"2023-08-04","current":-0.229111,"twenty":-11.590132,"median":-2.228997,"eighty":-0.710284,"marketCap":13574287},{"date":"2023-08-11","current":-1.293951,"twenty":-11.590132,"median":-2.228997,"eighty":-0.708289,"marketCap":60006335},{"date":"2023-08-18","current":-1.117918,"twenty":-11.590132,"median":-2.228997,"eighty":-0.708289,"marketCap":51842887},{"date":"2023-08-25","current":-1.121954,"twenty":-11.590132,"median":-2.228997,"eighty":-0.708289,"marketCap":52030046},{"date":"2023-09-01","current":-1.075542,"twenty":-11.590132,"median":-2.20645,"eighty":-0.708289,"marketCap":49877724},{"date":"2023-09-08","current":-1.32778,"twenty":-11.590132,"median":-2.204979,"eighty":-0.708289,"marketCap":61575126},{"date":"2023-09-15","current":-1.24101,"twenty":-11.590132,"median":-2.191847,"eighty":-0.708289,"marketCap":57551220},{"date":"2023-09-22","current":-1.03922,"twenty":-11.590132,"median":-2.171822,"eighty":-0.708289,"marketCap":48193298},{"date":"2023-09-29","current":-1.045273,"twenty":-11.590132,"median":-2.122085,"eighty":-0.708289,"marketCap":48474035},{"date":"2023-10-06","current":-1.636861,"twenty":-11.590132,"median":-2.080397,"eighty":-0.708289,"marketCap":75908600},{"date":"2023-10-13","current":-1.760348,"twenty":-11.590132,"median":-2.052187,"eighty":-0.708289,"marketCap":81635252},{"date":"2023-10-20","current":-1.581686,"twenty":-11.590132,"median":-2.0251,"eighty":-0.708289,"marketCap":73349883},{"date":"2023-10-23","current":-1.565921,"twenty":-11.590132,"median":-2.024672,"eighty":-0.708289,"marketCap":72618821},{"date":"2023-11-03","current":-1.723564,"twenty":-11.590132,"median":-1.987522,"eighty":-0.702187,"marketCap":79929440},{"date":"2023-11-10","current":-1.684041,"twenty":-11.590132,"median":-1.950372,"eighty":-0.702187,"marketCap":78096579},{"date":"2023-11-17","current":-2.528721,"twenty":-11.590132,"median":-1.94174,"eighty":-0.702187,"marketCap":89716486},{"date":"2023-11-24","current":-2.73437,"twenty":-11.590132,"median":-1.94174,"eighty":-0.702187,"marketCap":97012706},{"date":"2023-12-01","current":-2.73437,"twenty":-11.590132,"median":-1.94174,"eighty":-0.702187,"marketCap":97012706},{"date":"2023-12-08","current":-3.709298,"twenty":-11.590132,"median":-1.943002,"eighty":-0.703713,"marketCap":131602195},{"date":"2023-12-15","current":-3.777848,"twenty":-11.590132,"median":-1.943002,"eighty":-0.703713,"marketCap":134034268},{"date":"2023-12-22","current":-3.884481,"twenty":-11.590132,"median":-1.943002,"eighty":-0.703713,"marketCap":137817493},{"date":"2023-12-29","current":-3.991114,"twenty":-11.590132,"median":-1.94174,"eighty":-0.702187,"marketCap":141600719},{"date":"2024-01-05","current":-3.876864,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":137547263},{"date":"2024-01-12","current":-4.151063,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":147275557},{"date":"2024-01-19","current":-3.655982,"twenty":-11.590132,"median":-1.925948,"eighty":-0.698735,"marketCap":129710582},{"date":"2024-01-26","current":-3.671215,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":130251043},{"date":"2024-02-02","current":-3.655982,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":129710582},{"date":"2024-02-09","current":-3.770231,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":133764038},{"date":"2024-02-16","current":-4.567745,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":146476632},{"date":"2024-02-23","current":-4.146367,"twenty":-11.590132,"median":-1.962469,"eighty":-0.700461,"marketCap":132964028},{"date":"2024-03-01","current":-4.306491,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":138098817},{"date":"2024-03-08","current":-3.569078,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":114451760},{"date":"2024-03-15","current":-3.303609,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":105938819},{"date":"2024-03-22","current":-3.552223,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":113911255},{"date":"2024-03-28","current":-3.851402,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":123505205},{"date":"2024-04-05","current":-4.458187,"twenty":-11.590132,"median":-1.975159,"eighty":-0.700461,"marketCap":142963355},{"date":"2024-04-12","current":-4.470828,"twenty":-11.590132,"median":-1.975159,"eighty":-0.700461,"marketCap":143368733},{"date":"2024-04-19","current":-3.96096,"twenty":-11.590132,"median":-1.975159,"eighty":-0.700461,"marketCap":127018482},{"date":"2024-04-26","current":-3.96096,"twenty":-11.590132,"median":-1.987522,"eighty":-0.702187,"marketCap":127018482},{"date":"2024-05-03","current":-3.71656,"twenty":-11.590132,"median":-2.022834,"eighty":-0.702187,"marketCap":119181171},{"date":"2024-05-10","current":-3.775553,"twenty":-11.590132,"median":-2.06822,"eighty":-0.702187,"marketCap":121072936},{"date":"2024-05-17","current":-3.834546,"twenty":-11.590132,"median":-2.260612,"eighty":-0.702187,"marketCap":122964700},{"date":"2024-05-24","current":-3.455306,"twenty":-11.590132,"median":-2.481343,"eighty":-0.702187,"marketCap":110803356},{"date":"2024-05-31","current":-3.278327,"twenty":-11.590132,"median":-2.528721,"eighty":-0.702187,"marketCap":105128063},{"date":"2024-06-07","current":-3.253044,"twenty":-11.590132,"median":-2.569513,"eighty":-0.702187,"marketCap":104317306},{"date":"2024-06-14","current":-3.239859,"twenty":-11.590132,"median":-2.650451,"eighty":-0.700461,"marketCap":95128735},{"date":"2024-06-21","current":-2.963734,"twenty":-11.590132,"median":-2.695417,"eighty":-0.698735,"marketCap":87021172},{"date":"2024-06-28","current":-3.203042,"twenty":-11.590132,"median":-2.73437,"eighty":-0.693557,"marketCap":94047727},{"date":"2024-07-05","current":-3.046572,"twenty":-11.590132,"median":-2.762551,"eighty":-0.693557,"marketCap":89453441},{"date":"2024-07-12","current":-3.59882,"twenty":-11.590132,"median":-2.788793,"eighty":-0.693557,"marketCap":105668567},{"date":"2024-07-15","current":-3.534391,"twenty":-11.590132,"median":-2.795067,"eighty":-0.693557,"marketCap":103776802},{"date":"2024-08-02","current":-3.100103,"twenty":-11.814457,"median":-2.833386,"eighty":-0.682688,"marketCap":91025218},{"date":"2024-08-09","current":-3.14156,"twenty":-11.814457,"median":-2.87737,"eighty":-0.682688,"marketCap":92242494},{"date":"2024-08-16","current":-2.755069,"twenty":-11.814457,"median":-2.894519,"eighty":-0.682688,"marketCap":91446261},{"date":"2024-08-23","current":-2.975149,"twenty":-11.814457,"median":-2.918362,"eighty":-0.682688,"marketCap":98751140},{"date":"2024-08-30","current":-2.869185,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":95233976},{"date":"2024-09-06","current":-2.657256,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":88199648},{"date":"2024-09-13","current":-2.600199,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":86305791},{"date":"2024-09-20","current":-2.445328,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":81165321},{"date":"2024-09-27","current":-2.445328,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":81165321},{"date":"2024-10-04","current":-2.404572,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":79812565},{"date":"2024-10-11","current":-2.46163,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":81706423},{"date":"2024-10-18","current":-2.494234,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":82788627},{"date":"2024-10-25","current":-2.469781,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":81976974},{"date":"2024-10-31","current":-2.518688,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":83600280},{"date":"2024-11-08","current":-2.543141,"twenty":-11.826919,"median":-2.927982,"eighty":-0.68268,"marketCap":84411933},{"date":"2024-11-15","current":-1.866798,"twenty":-11.826919,"median":-2.927982,"eighty":-0.684226,"marketCap":73860442},{"date":"2024-11-22","current":-1.780462,"twenty":-11.826919,"median":-2.927982,"eighty":-0.711322,"marketCap":70443968},{"date":"2024-11-29","current":-1.998621,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":79075443},{"date":"2024-12-06","current":-1.826205,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":72253794},{"date":"2024-12-13","current":-1.745275,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":69051795},{"date":"2024-12-20","current":-1.583415,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":62647798},{"date":"2024-12-27","current":-1.829724,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":72393011},{"date":"2025-01-03","current":-2.332897,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":92301089},{"date":"2025-01-10","current":-2.132332,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":84365701},{"date":"2025-01-17","current":-2.05492,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":81302920},{"date":"2025-01-24","current":-2.090107,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":82695094},{"date":"2025-01-31","current":-2.068995,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":81859790},{"date":"2025-02-07","current":-2.019733,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":79910747},{"date":"2025-02-14","current":-1.738893,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":82256942},{"date":"2025-02-21","current":-1.751103,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":82834183},{"date":"2025-02-28","current":-1.549757,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":73309695},{"date":"2025-03-07","current":-1.629075,"twenty":-11.851844,"median":-2.928824,"eighty":-0.719421,"marketCap":77061766},{"date":"2025-03-14","current":-1.659582,"twenty":-11.851844,"median":-2.928824,"eighty":-0.719421,"marketCap":78504871},{"date":"2025-03-21","current":-1.690089,"twenty":-11.851844,"median":-2.928824,"eighty":-0.732399,"marketCap":79947975},{"date":"2025-03-28","current":-1.604669,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":75907283},{"date":"2025-04-04","current":-1.39112,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":65805553},{"date":"2025-04-11","current":-1.250788,"twenty":-11.839382,"median":-2.927982,"eighty":-0.739388,"marketCap":59167274},{"date":"2025-04-17","current":-1.262991,"twenty":-11.839382,"median":-2.927982,"eighty":-0.739388,"marketCap":59744515},{"date":"2025-04-25","current":-1.427729,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":67537278},{"date":"2025-05-02","current":-1.439932,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":68114520},{"date":"2025-05-09","current":-1.372816,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":64939691},{"date":"2025-05-16","current":-1.403323,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":66382795},{"date":"2025-05-23","current":-1.482641,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":70134866},{"date":"2025-05-30","current":-1.555858,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":73598316},{"date":"2025-06-06","current":-1.446033,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":68403141},{"date":"2025-06-13","current":-1.412475,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":66815726},{"date":"2025-06-20","current":-1.168169,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":60064929},{"date":"2025-06-27","current":-1.162499,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":59773352},{"date":"2025-07-03","current":-1.134145,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":58315466},{"date":"2025-07-11","current":-1.377986,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":70853291},{"date":"2025-07-18","current":-1.440364,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":74060641},{"date":"2025-07-25","current":-1.536766,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":79017456},{"date":"2025-08-01","current":-1.627498,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":83682693},{"date":"2025-08-08","current":-1.585392,"twenty":-11.864307,"median":-2.927982,"eighty":-0.737322,"marketCap":81517693},{"date":"2025-08-15","current":-1.625328,"twenty":-11.864307,"median":-2.915434,"eighty":-0.737322,"marketCap":90660791},{"date":"2025-08-22","current":-1.683081,"twenty":-11.864307,"median":-2.877336,"eighty":-0.737322,"marketCap":93882241},{"date":"2025-08-29","current":-1.776585,"twenty":-11.864307,"median":-2.863852,"eighty":-0.737322,"marketCap":99097921},{"date":"2025-09-05","current":-1.991095,"twenty":-11.876769,"median":-2.857435,"eighty":-0.736288,"marketCap":111063305},{"date":"2025-09-12","current":-1.925092,"twenty":-11.864307,"median":-2.851018,"eighty":-0.737322,"marketCap":107381648},{"date":"2025-09-19","current":-1.67208,"twenty":-11.864307,"median":-2.851018,"eighty":-0.737322,"marketCap":93268631},{"date":"2025-09-26","current":-1.853589,"twenty":-11.864307,"median":-2.851018,"eighty":-0.737322,"marketCap":103393187},{"date":"2025-10-03","current":-1.980095,"twenty":-11.864307,"median":-2.83596,"eighty":-0.737322,"marketCap":110449695},{"date":"2025-10-10","current":-2.315611,"twenty":-11.864307,"median":-2.802915,"eighty":-0.737322,"marketCap":129164782},{"date":"2025-10-17","current":-2.227607,"twenty":-11.864307,"median":-2.73437,"eighty":-0.737322,"marketCap":124255907},{"date":"2025-10-24","current":-2.28811,"twenty":-11.864307,"median":-2.673112,"eighty":-0.737322,"marketCap":127630759},{"date":"2025-10-31","current":-2.062599,"twenty":-11.864307,"median":-2.649105,"eighty":-0.737322,"marketCap":115051766},{"date":"2025-11-07","current":-2.211106,"twenty":-11.864307,"median":-2.567594,"eighty":-0.737322,"marketCap":123335493},{"date":"2025-11-14","current":-2.0901,"twenty":-11.864307,"median":-2.53499,"eighty":-0.737322,"marketCap":116585789},{"date":"2025-11-21","current":-2.824005,"twenty":-11.864307,"median":-2.526839,"eighty":-0.737322,"marketCap":175754756},{"date":"2025-11-28","current":-3.109578,"twenty":-11.864307,"median":-2.526839,"eighty":-0.737322,"marketCap":193527709},{"date":"2025-12-05","current":-2.716121,"twenty":-11.864307,"median":-2.526839,"eighty":-0.737322,"marketCap":169040530},{"date":"2025-12-12","current":-2.506701,"twenty":-11.864307,"median":-2.518688,"eighty":-0.737322,"marketCap":156007031},{"date":"2025-12-19","current":-0.46961,"twenty":-11.801994,"median":-2.505871,"eighty":-0.722332,"marketCap":29226633},{"date":"2025-12-26","current":-0.461931,"twenty":-11.590132,"median":-2.494234,"eighty":-0.710167,"marketCap":28748738},{"date":"2026-01-02","current":-0.420047,"twenty":-11.390732,"median":-2.469781,"eighty":-0.68148,"marketCap":26142039},{"date":"2026-01-09","current":-0.446637,"twenty":-11.216257,"median":-2.464118,"eighty":-0.673408,"marketCap":27796898},{"date":"2026-01-16","current":-0.425822,"twenty":-10.967006,"median":-2.453479,"eighty":-0.659291,"marketCap":26501447},{"date":"2026-01-23","current":-0.420555,"twenty":-10.431119,"median":-2.445328,"eighty":-0.65328,"marketCap":26173635},{"date":"2026-01-30","current":-0.34345,"twenty":-10.119556,"median":-2.404572,"eighty":-0.642171,"marketCap":21374938},{"date":"2026-02-06","current":-0.320477,"twenty":-9.795531,"median":-2.350491,"eighty":-0.624554,"marketCap":19945202},{"date":"2026-02-13","current":-0.345861,"twenty":-9.421655,"median":-2.315611,"eighty":-0.614743,"marketCap":21525020},{"date":"2026-02-20","current":-0.350015,"twenty":-9.12284,"median":-2.255108,"eighty":-0.605072,"marketCap":23467113},{"date":"2026-02-27","current":-0.35752,"twenty":-8.530345,"median":-2.227607,"eighty":-0.589095,"marketCap":23970291},{"date":"2026-03-06","current":-0.363016,"twenty":-8.242307,"median":-2.211106,"eighty":-0.576686,"marketCap":24338760},{"date":"2026-03-13","current":-0.372766,"twenty":-7.777016,"median":-2.194605,"eighty":-0.562871,"marketCap":24992495},{"date":"2026-03-20","current":-0.379562,"twenty":-7.699467,"median":-2.167104,"eighty":-0.554569,"marketCap":25448129},{"date":"2026-03-27","current":-0.357402,"twenty":-7.533291,"median":-2.132332,"eighty":-0.544676,"marketCap":23962367}],"updateTime":1774786557447},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VTGN\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2611486155","title":"VistaGen Therapeutics Faces Securities Class Action Over Alleged Misleading Statements","url":"https://stock-news.laohu8.com/highlight/detail?id=2611486155","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611486155?lang=en_us&edition=fundamental","pubTime":"2026-02-16 22:51","pubTimestamp":1771253460,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics Inc. is facing a federal securities class action lawsuit alleging that the company and its executives made false or misleading statements regarding the likelihood of success for its fasedienol clinical trials. The complaint claims that positive assertions about the PALISADE-2 and PALISADE-3 trials were misleading, causing investors to purchase stock at inflated prices. After these issues came to light, the company's stock price dropped by over 81%. Investors who acquired VistaGen securities between April 1, 2024, and December 16, 2025, have until March 16, 2026, to seek lead plaintiff status in the case.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260216:nNDL80Vpyl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"gpt_icon":0},{"id":"2611115353","title":"High-Risk Warning: Analyst Flags Significant Uncertainties for Vistagen Therapeutics Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2611115353","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611115353?lang=en_us&edition=fundamental","pubTime":"2026-02-14 14:01","pubTimestamp":1771048900,"startTime":"0","endTime":"0","summary":"Vistagen Therapeutics Inc. (VTGN) has disclosed a new risk, in the Accounting & Financial Operations category. The analyst notes that investing in ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/high-risk-warning-analyst-flags-significant-uncertainties-for-vistagen-therapeutics-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/high-risk-warning-analyst-flags-significant-uncertainties-for-vistagen-therapeutics-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4539","BK4211","VTGN","BK4139","ISBC","LENZ"],"gpt_icon":0},{"id":"2611162431","title":"VistaGen Therapeutics Faces Investor Class Action Over Failed Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2611162431","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611162431?lang=en_us&edition=fundamental","pubTime":"2026-02-14 02:18","pubTimestamp":1771006688,"startTime":"0","endTime":"0","summary":"A class action lawsuit has been filed against VistaGen Therapeutics Inc. on behalf of investors who purchased the company’s common stock between April 1, 2024 and December 16, 2025. The litigation alleges that VistaGen made false and misleading statements regarding the viability of its Phase 3 PALISADE-3 trial study of fasedienol, a treatment for social anxiety disorder. According to the complaint, the company failed to disclose material adverse facts about the trial, which ultimately did not meet its primary or secondary endpoints. Following the announcement of the trial results on December 17, 2025, VistaGen’s stock price fell by more than 80%. Shareholders who suffered losses during the class period may be eligible to participate in the litigation and have until March 16, 2026 to seek appointment as lead plaintiff. All representation is on a contingency fee basis, with no fees or expenses required from shareholders.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nNDL15hXZJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","BK4585","LU2095319765.USD","IE00B3QW5Z07.USD","SG9999014013.SGD","VTGN","LU0314104364.USD","SG9999014005.SGD","LU2210149790.SGD","SG9999014021.USD","BK4112","LU2210150020.SGD","SG9999014039.USD","BK4588","IE00B64PRP62.GBP","IE00BGHQF748.EUR","BK4139","NDAQ"],"gpt_icon":0},{"id":"2611470152","title":"Stifel Nicolaus Reaffirms Their Hold Rating on VistaGen Therapeutics (VTGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2611470152","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611470152?lang=en_us&edition=fundamental","pubTime":"2026-02-13 20:56","pubTimestamp":1770987394,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Paul Matteis maintained a Hold rating on VistaGen Therapeutics today and set a price target of $1.00. According to TipRanks...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-reaffirms-their-hold-rating-on-vistagen-therapeutics-vtgn-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-reaffirms-their-hold-rating-on-vistagen-therapeutics-vtgn-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SF","VTGN"],"gpt_icon":0},{"id":"2611908419","title":"VistaGen fiscal Q3 net loss widens to $18.9 mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2611908419","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611908419?lang=en_us&edition=fundamental","pubTime":"2026-02-13 05:37","pubTimestamp":1770932266,"startTime":"0","endTime":"0","summary":"VistaGen fiscal Q3 net loss widens to $18.9 mlnOverviewBiopharmaceutical firm's fiscal Q3 net loss widened to $18.9 mlnR&D expenses increased due to PALISADE Program for social anxiety disorderOutlook","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nL1N3Z81IT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VTGN"],"gpt_icon":0},{"id":"2611627908","title":"VistaGen Therapeutics Q3 EPS $(0.45) Misses $(0.44) Estimate, Sales $303.000K Miss $366.000K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2611627908","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611627908?lang=en_us&edition=fundamental","pubTime":"2026-02-13 05:31","pubTimestamp":1770931908,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics (NASDAQ:VTGN) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(0.44) by 2.74 percent. This is a 2.17 percent increase over losses of $(0.46) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/02/50597578/vistagen-therapeutics-q3-eps-0-45-misses-0-44-estimate-sales-303-000k-miss-366-000k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"VistaGen Therapeutics Q3 EPS $(0.45) Misses $(0.44) Estimate, Sales $303.000K Miss $366.000K Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN"],"gpt_icon":0},{"id":"2611086909","title":"BRIEF-VistaGen Q3 EPS USD -0.45","url":"https://stock-news.laohu8.com/highlight/detail?id=2611086909","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611086909?lang=en_us&edition=fundamental","pubTime":"2026-02-13 05:30","pubTimestamp":1770931846,"startTime":"0","endTime":"0","summary":"BRIEF-VistaGen Q3 EPS USD -0.45\n\n\nFeb 12 (Reuters) - VistaGen Q3 net income USD -18.899 million.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nPLX0A9F89:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"gpt_icon":0},{"id":"2611790850","title":"Vistagen Reports Fiscal Year 2026 Third Quarter Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2611790850","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611790850?lang=en_us&edition=fundamental","pubTime":"2026-02-13 05:30","pubTimestamp":1770931803,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nTUA9P9BRN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VTGN","BK4139"],"gpt_icon":0},{"id":"2609511653","title":"Nasdaq Warns VistaGen Therapeutics Over Minimum Bid Price Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2609511653","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609511653?lang=en_us&edition=fundamental","pubTime":"2026-02-07 05:13","pubTimestamp":1770412384,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics Inc. has received a notice from the Nasdaq Stock Market indicating that the company's common stock has failed to meet the minimum bid price requirement of $1.00 per share for the past 30 consecutive business days, as mandated by Nasdaq Listing Rule 5550. While the notice does not immediately affect the company's listing, VistaGen has 180 calendar days, until August 3, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 per share for 10 consecutive business days. If the company does not meet this requirement, it may be granted an additional 180-day compliance period, subject to meeting other Nasdaq listing standards. Failure to regain compliance could result in the delisting of VistaGen's common stock from the Nasdaq Capital Market.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL6vRp0R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VTGN"],"gpt_icon":0},{"id":"2608362906","title":"VistaGen Therapeutics Inc. to Report Third Quarter Results and Host Corporate Update Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2608362906","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608362906?lang=en_us&edition=fundamental","pubTime":"2026-02-04 21:31","pubTimestamp":1770211884,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VistaGen Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on February 04, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDL1mRCMN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"gpt_icon":0},{"id":"2608629783","title":"Press Release: Vistagen to Report Fiscal Year 2026 Third Quarter Results and Host Corporate Update Conference Call on February 12, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2608629783","media":"Dow Jones","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608629783?lang=en_us&edition=fundamental","pubTime":"2026-02-04 21:31","pubTimestamp":1770211860,"startTime":"0","endTime":"0","summary":"Vistagen , a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today announced it will host a conference call and webcast on Thursday, February 12, 2026, at 2:00 p.m. Pacific Time  to report results for its fiscal year 2026 third quarter ended December 31, 2025, and provide a corporate update.The conference call is being webcast live, and a link can be found under \"Events\" in the Investors section of the Company's website. Please click on the webcast link and follow the prompts for registration and access at least 10 minutes before the call. The webcast will be archived on Vistagen's website shortly after the call and will be available for at least 90 days.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","HST","BK4218","BK4588","BK4585","BK4181","BK4139"],"gpt_icon":0},{"id":"2607087145","title":"Vistagen Therapeutics (VTGN) Faces Securities Litigation Following 80% Stock Collapse [January 2026]","url":"https://stock-news.laohu8.com/highlight/detail?id=2607087145","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607087145?lang=en_us&edition=fundamental","pubTime":"2026-01-29 20:59","pubTimestamp":1769691557,"startTime":"0","endTime":"0","summary":"Overview: When Clinical Failure Meets Market Expectations On December 17, 2025, investors in Vistagen Therapeutics, Inc. ($VTGN) experienced a sing...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/vistagen-therapeutics-vtgn-faces-securities-litigation-following-80-stock-collapse-january-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/vistagen-therapeutics-vtgn-faces-securities-litigation-following-80-stock-collapse-january-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VTGN","BK4139"],"gpt_icon":0},{"id":"2593945566","title":"VistaGen Therapeutics Reports Phase 3 Fasedienol Trial Fails to Meet Primary Endpoint in Social Anxiety Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2593945566","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593945566?lang=en_us&edition=fundamental","pubTime":"2025-12-23 06:29","pubTimestamp":1766442581,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics Inc. announced that the PALISADE-3 Phase 3 clinical trial evaluating intranasal fasedienol for the acute treatment of social anxiety disorder did not achieve its primary endpoint. The study found no treatment difference between fasedienol and placebo as measured by the least squares mean change from baseline on the Subjective Units of Distress Scale, nor for the secondary endpoints. The safety profile of fasedienol in the trial was consistent with previous clinical studies. The results have already been presented.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VistaGen Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nNDL9r34z1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"gpt_icon":0},{"id":"2592908095","title":"Vistagen Therapeutics Inc : William Blair Cuts to Market Perform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2592908095","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592908095?lang=en_us&edition=fundamental","pubTime":"2025-12-18 20:06","pubTimestamp":1766059560,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nFWN3XO0V8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VTGN","BK4139"],"gpt_icon":0},{"id":"2592592908","title":"Vistagen Therapeutics Inc : Maxim Group Cuts to Hold From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2592592908","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592592908?lang=en_us&edition=fundamental","pubTime":"2025-12-18 12:32","pubTimestamp":1766032373,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nFWN3XO03H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VTGN","BK4139"],"gpt_icon":0},{"id":"2592948085","title":"Vistagen Therapeutics Cut to Hold From Buy by Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2592948085","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592948085?lang=en_us&edition=fundamental","pubTime":"2025-12-18 04:46","pubTimestamp":1766004360,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VTGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 17, 2025 15:46 ET (20:46 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LENZ","BK4007","BK4139","VTGN"],"gpt_icon":0},{"id":"2592910836","title":"Sector Update: Health Care Stocks Softer Wednesday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2592910836","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592910836?lang=en_us&edition=fundamental","pubTime":"2025-12-18 02:59","pubTimestamp":1765997946,"startTime":"0","endTime":"0","summary":"Health care stocks were lower Wednesday afternoon, with the NYSE Health Care Index and the State Street Health Care Select Sector SPDR ETF  each decreasing 0.2%.The iShares Biotechnology ETF  eased 0.1%.In corporate news, Vistagen Therapeutics  shares tumbled 80% after Maxim downgraded the company to hold from buy.The White House is set to announce deals with Novartis  and Roche on drug pricing, Bloomberg reported Wednesday. Other drugmakers may be included in the announcement, the report said. Novartis shares rose 0.4%.Medline  shares surged 30% in their trading debut on Nasdaq Wednesday after the company priced an upsized IPO of about 216 million class A shares at $29 per share.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","LU0208291251.USD","BK4578","XLV","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4581","BK4007","BK4585","IE0002141913.USD","NVS","LU0320765489.SGD","LABU","LU0070302665.USD","BK4139","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","IBB","LU0211331839.USD","BK4532","VTGN","IE0009355771.USD","XBI"],"gpt_icon":1},{"id":"2592261913","title":"Vistagen Therapeutics Shares Tumble in Premarket as Anxiety Drug Test Miss Targets","url":"https://stock-news.laohu8.com/highlight/detail?id=2592261913","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592261913?lang=en_us&edition=fundamental","pubTime":"2025-12-17 22:05","pubTimestamp":1765980300,"startTime":"0","endTime":"0","summary":"Vistagen Therapeutics Shares fell sharply in premarket trading Wednesday after it said that its phase 3 trials of its social anxiety therapy didn't meet its endpoints.The stock traded 73% lower ahead of the morning bell at $1.18.The clinical-stage biopharmaceutical company said Wednesday that its experimental intranasal treatment called fasedienol didn't meet either of its primary or secondary endpoints in the Palisade-3 phase 3 study.The drug is intended to treat acute social anxiety disorder but didn't demonstrate statistically significant improvements.The phase 3 study tested whether a single dose of fasedienol could reduce anxiety during a public speaking challenge. Participants could later continue using the drug for up to a year in daily life.Chief Executive Shawn Singh said the company is reviewing the data and plans to seek feedback from the Food and Drug Administration.\"We are disappointed by the unexpected results of this public speaking challenge trial, which are inconsisten","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","VTGN","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2592913314","title":"BRIEF-Vistagen Announces Topline Results From Palisade-3 Phase 3 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2592913314","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592913314?lang=en_us&edition=fundamental","pubTime":"2025-12-17 21:50","pubTimestamp":1765979408,"startTime":"0","endTime":"0","summary":"BRIEF-Vistagen Announces Topline Results From Palisade-3 Phase 3 StudyDec 17 (Reuters) - VistaGen Therapeutics Inc VTGN.O:VISTAGEN ANNOUNCES TOPLINE RESULTS FROM PALISADE-3 PHASE 3 PUBLIC SPEAKING CHA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nTUA4ZWW0K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"gpt_icon":0},{"id":"2592913918","title":"VistaGen Therapeutics Reports Phase 3 Trial of Fasedienol for Social Anxiety Disorder Fails to Meet Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2592913918","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592913918?lang=en_us&edition=fundamental","pubTime":"2025-12-17 21:30","pubTimestamp":1765978247,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics Inc. announced topline results from the PALISADE-3 Phase 3 clinical study evaluating intranasal fasedienol for the acute treatment of social anxiety disorder. The study did not demonstrate a statistically significant improvement on the primary endpoint, as measured by the Subjective Units of Distress Scale , with results showing no significant difference between fasedienol and placebo. No treatment difference was observed for secondary endpoints. The safety profile of fasedienol remained favorable and consistent with previous clinical trials. The results of the study have already been presented. VistaGen is reviewing the results, assessing their impact on ongoing studies, and plans to consult with the FDA while implementing cash preservation measures to extend its operational runway.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nNDL2CVTRT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":72,"code":"91000000","status":"200"}]}}